APA (7th ed.) Citation

Grafetstätter, M., Johnson, T. S., Pletsch-Borba, L., Katzke, V., Hoffmeister, M., Bugert, P., . . . Kühn, T. (2019). Plasma Fibrinogen and sP-Selectin are associated with the risk of lung cancer in a prospective study. Cancer epidemiology, biomarkers & prevention, 28(7), . https://doi.org/10.1158/1055-9965.EPI-18-1285

Chicago Style (17th ed.) Citation

Grafetstätter, Mirja, Theron S. Johnson, Laura Pletsch-Borba, Verena Katzke, Michael Hoffmeister, Peter Bugert, Rudolf Kaaks, and Tilman Kühn. "Plasma Fibrinogen and SP-Selectin Are Associated with the Risk of Lung Cancer in a Prospective Study." Cancer Epidemiology, Biomarkers & Prevention 28, no. 7 (2019). https://doi.org/10.1158/1055-9965.EPI-18-1285.

MLA (9th ed.) Citation

Grafetstätter, Mirja, et al. "Plasma Fibrinogen and SP-Selectin Are Associated with the Risk of Lung Cancer in a Prospective Study." Cancer Epidemiology, Biomarkers & Prevention, vol. 28, no. 7, 2019, https://doi.org/10.1158/1055-9965.EPI-18-1285.